India, Feb. 4 -- Nashik-based Datar Cancer Genetics (DCG) has launched Exacta AI, a next generation multi-analyte artificial intelligence (AI)-driven platform providing optimised treatment options for cancer patients who have exhausted the standard options.

It integrates a 360degtumour work-up and AI assisted data analysis to decode complex tumour interactome data-including molecular (NGS: DNA+RNA), proteomic, genomic, functional, and clinical insights-providing personalised treatment options with thorough risk-benefit analysis.

Exacta AI processes real-time wet lab data and integrates it with knowledge from multiple sources to assess drug synergy, interactions, toxicity, and contraindications for Anti-body Drug Conjugates (ADC)s, Check...